News

Maximize Efficiency with Vishay's New PowerPAK MOSFET

Maximize Efficiency with Vishay's New PowerPAK MOSFET

Introducing Vishay's Powerful New MOSFET

Vishay Intertechnology, Inc. has unveiled a state-of-the-art 40V TrenchFET Gen V n-channel power MOSFET designed with a PowerPAK 10x12 package, enhancing efficiency and power density for various industrial applications. Notably, this innovative device boasts an impressive on-resistance of just 0.34 m?, optimizing power handling while minimizing losses during operation.

Enhanced Features for Superior Performance

With a unique bond-wireless design, the SiJK140E MOSFET achieves a high continuous drain current rating of up to 795 A, eclipsing conventional TO-263-7L solutions, which are limited to 200 A. This remarkable improvement enables designers to rely on a single device rather than deploying dual components for similar low on-resistance, thus simplifying designs and enhancing reliability.

Dimensions and Thermal Management

The PowerPAK's design occupies a footprint of 120 mm², saving an impressive 27% PCB space compared to its TO-263-7L counterpart. Additionally, the MOSFET’s low thermal resistance (RthJC) of 0.21 °C/W ensures efficient heat dissipation, making it an ideal choice for applications demanding high reliability alongside superior thermal performance.

Applications Ranging from Robotics to Power Tools

This versatile MOSFET serves multiple uses, particularly in synchronous rectification, hot swap switching, and OR-ing functionalities. Common applications include motor drive controls, power tools, welding systems, plasma cutters, battery management systems, robotics, and even advanced technologies like 3D printers. Its robust design helps prevent shoot-through scenarios thanks to a high threshold voltage of 2.4 Vgs, ensuring safety and consistent operation.

Performance vs. Competitors

When compared to other devices in its class, the SiJK140E excels in several categories. Competition analysis reveals that it provides lower on-resistance than many 40 V MOSFETs within the market, alongside enhancements in thermal performance and power density. This competitive edge is pivotal for engineers looking to innovate while mitigating the challenges of component size and heat management.

Availability and Market Presence

Vishay is eager to announce that samples and production quantities of the SiJK140E are currently available, with anticipated lead times around 36 weeks. As a part of one of the largest portfolios of discrete semiconductors and passive electronic components worldwide, Vishay continues to establish itself as a critical player in the automotive, industrial, telecommunications, consumer, military, aerospace, and medical sectors.

Positioned as "The DNA of tech," Vishay Intertechnology, Inc. holds a Fortune 1,000 Company status and maintains its listing on the NYSE (VSH), underlining the brand’s strength and reach within the electronics market. For further inquiries about Vishay products, customers can find more comprehensive details at their official website.

Frequently Asked Questions

What is the on-resistance of the new SiJK140E MOSFET?

The SiJK140E MOSFET features an on-resistance of 0.34 m? at 10 V, making it one of the best in its class.

What applications can the SiJK140E MOSFET be used for?

This MOSFET is suitable for applications such as motor drive controls, power tools, welding equipment, and battery management systems.

How does the SiJK140E compare to traditional devices?

Compared to conventional TO-263-7L solutions, the SiJK140E offers significantly lower on-resistance and higher current capacity.

What is the maximum continuous drain current for the SiJK140E?

The maximum continuous drain current for the SiJK140E is 795 A, enabling enhanced power density in various designs.

Where can I find more information about Vishay products?

For more details about Vishay's extensive product offerings, you can visit their official site or contact their representatives directly.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 0

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 2

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 2

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 2

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 2

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 1

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 1

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading

Top 5 Most Recently Viewed Articles

Tilray Brands Achieves Exceptional Performance in Q1 2025

Updated Category News Views 226

Tilray Brands Delivers Record Q1 Revenue Tilray Brands (NASDAQ: TLRY) has announced an impressive net revenue of $200 million for its first fiscal quarter, showcasing a remarkable 13% increase from the previous year. The significant boost can largely be attributed to the exponential growth within its beverage sector, including both traditional craft beers and innovative...

Continue Reading
Exor N.V. Announces Impressive Growth and Strategic Moves

Updated Category News Views 361

Exor N.V. Reports Robust Year-End Performance Exor N.V. has once again demonstrated significant growth and strategic financial management through its latest annual results. The company reported an impressive 9% growth in Net Asset Value (NAV) per share for the fiscal year, reaching €38.2 billion by year-end. This financial achievement reflects Exor's robust operational...

Continue Reading
Integral Ad Science Faces Legal Challenge – Join the Action

Updated Category News Views 102

Integral Ad Science Holding Corp. Faces Securities Fraud Allegations Levi & Korsinsky, LLP is reaching out to the investors of Integral Ad Science Holding Corp. (NASDAQ: IAS), as there is an ongoing class action securities lawsuit that could allow affected investors to recover losses. Understanding the Class Action Details This class action lawsuit aims to represent those...

Continue Reading
Innovative Oncology Solutions Unveiled by Powered Research

Updated Category News Views 132

Expanding Horizons: Powered Research's New Oncology Services For over a decade, Powered Research has earned its reputation as a premier preclinical contract research organization (CRO), particularly in the field of ophthalmology. Today, the company takes a monumental step forward by launching an extensive suite of oncology preclinical services. This new direction is set...

Continue Reading
Discover Why Jim Cramer Recommends Dominion Energy Stock

Updated Category News Views 65

Jim Cramer Sees Potential in Dominion Energy In a recent episode of CNBC's programming, well-known financial commentator Jim Cramer highlighted Dominion Energy, Inc. (D) as a promising buy. He stated, "We need cheap power," which underscores the increasing demand for affordable energy solutions in today's unpredictable market landscape. Analyst Ratings for Dominion Energy...

Continue Reading